Fujirebio Diagnostics sought to enhance collaboration and enable swifter vaccine manufacturing. To do so, the Japanese pharma leader transitioned from a manual, paper-based process to a computerized system to save time while maintaining compliance and providing a scalable infrastructure for the future. The personnel at the Malvern, Penn. campus identified a major opportunity to save time and paper, while still retaining compliance by automating the acquisition of equipment data and generating electronic reports for review and approval.
“We installed the equipment monitoring system to electronically capture data from Fujirebio’s temperature-controlled areas. The new monitoring system also provides the company with a scalable infrastructure which we can implement other electronic data capture projects as we go forward.”
-Mike Koch, Vice President of Supply Chain, Fujirebio Diagnostics
Goals
- To enhance collaboration and enable swifter vaccine manufacturing
- To replace an existing paper-based record system and manual process
Challenge
- A significant amount of time is spent each day manually reviewing reports.
- The existing paper-based system was time-consuming and vulnerable to reporting errors.
- A new system must enable the company to remain in compliance with federal regulations.
Solutions
- AVEVA™ System Platform
- AVEVA™ Work Tasks
- AVEVA™ Historian
- AVEVA™ InTouch HMI
Results
- The electronic initiative helps produce 75 million tests.
- The equipment monitoring system saves about 1,100 man-hours per year.
- The data reviewing time is reduced from 15+ hours to just minutes.
